Cooperman LH (1970): Succinylcholine-induced hyperkalemia in neuromuscular disease
Araujo MS, Guastali MD, Paulini F, Silva AN, Tsunemi MH, Fontes PK, Castilho ACS, Landim-Alvarenga FC (2020) Molecular and cellular effects of insulin-like growth factor-1 and LongR3-IGF-1 on in vitro maturation of bovine oocytes: comparative study
At the highest recommended dose (15mg per week), patients in clinical trials lost an average of 48 lbs in 72 weeks
GLP-1 Elevate utilizes clinically studied plant extracts-Metabolaid (lemon verbena + hibiscus), CQR-300 (cissus quadrangularis), and a polyphenol blend (green tea, pomegranate, grape)-to stimulate GLP-1 production, inhibit its breakdown, and support gut health
These are physician-prescribed and sourced from FDA-regulated facilities at Revolution Health
The ADA highlights the benefits of combining GLP-1 receptor agonists with SGLT2 inhibitors, stating: Combined use [of GLP-1 RAs and SGLT2 inhibitors] may be considered for additive cardio-kidney protection